v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash Flow from Operating Activities:    
Net loss available to common stockholders $ (8,069) $ (14,954)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,262 1,265
Amortization of debt issuance costs 165 39
Share-based compensation expense 1,620 2,454
Amortization of prepaid assets 2,095
Change in fair value of warrants liabilities (1,339)
Inventory reserve (987) 511
Loss on disposal of assets 11
Other (6) 127
Changes in operating assets and liabilities:    
Accounts receivable (1,831) (2,901)
Inventories 3,703 (6,877)
Prepaid expenses and other assets (225) (257)
Accounts payable 4,875 466
Accrued and other liabilities (73) 60
Cash Used in Operating Activities (894) (17,972)
Cash Flow from Investing Activities:    
Capital expenditures (10) (198)
Cash Used in Investing Activities (10) (198)
Cash Flow from Financing Activities:    
Proceeds from revolving lines of credit 6,764 7,500
Payments on revolving line of credit (16,291) (5,000)
Proceeds from Alphia Facility 2,792
Payment of loan issuance costs (242) (7)
Proceeds from warrant liabilities 2,208
Payments on term loans (650)
Cash (Used in) Provided by Financing Activities (4,769) 1,843
Net decrease in cash and cash equivalents and restricted cash (5,673) (16,327)
Total cash and cash equivalents and restricted cash, beginning of period 9,473 28,942
Total cash and cash equivalents and restricted cash, end of period 3,800 12,615
Cash paid during the quarter for:    
Interest $ 489 $ 279

Source